Long-Term Effectiveness of Baricitinib and Other b/tsDMARDs in Patients with Rheumatoid Arthritis with Early Low Disease Activity or Remission: 2-Year Data from the RA-BE-REAL Study

In a routine clinical practice population, achieving early remission/LDA was associated with maintained remission/LDA at 2 years as well as long-term improvement in pain, physical function, and quality of life in both cohorts.

Authors

Institutions

Publication Details

Journal
Rheumatology and Therapy
Published
2025-12-23
DOI
https://doi.org/10.1007/s40744-025-00815-0
Primary Topic
Rheumatoid Arthritis Research and Therapies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Long-Term Effectiveness of Baricitinib and Other b/tsDMARDs in Patients with Rheumatoid Arthritis with Early Low Disease Activity or Remission: 2-Year Data from the RA-BE-REAL Study

Andrew J.K. Östör, K. Ng, E. Haladyj, Josef S. Smolen et al.
Rheumatology and Therapy
Rheumatoid Arthritis Research and Therapies
article

Long-Term Effectiveness of Baricitinib and Other b/tsDMARDs in Patients with Rheumatoid Arthritis with Early Low Disease Activity or Remission: 2-Year Data from the RA-BE-REAL Study

Andrew J.K. Östör, K. Ng, E. Haladyj, Josef S. Smolen, Samuel Ogwu, Christopher J. Edwards, Rieke Alten, Yuko Kaneko
article en

Abstract

In a routine clinical practice population, achieving early remission/LDA was associated with maintained remission/LDA at 2 years as well as long-term improvement in pain, physical function, and quality of life in both cohorts.

Rheumatology and TherapyVol. 13(1)
Eli Lilly (United States) (US), Keio University (JP), University Hospital Southampton NHS Foundation Trust (GB), Cabrini Hospital (AU), NIHR Southampton Biomedical Research Centre (GB), Schlosspark-Klinik (DE), Medical University of Vienna (AT)
Eli Lilly and Company, Pfizer, Biogen, Celltrion
Openalex Percentile: Top 28%
Rheumatoid Arthritis Research and Therapies
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.